Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference

Alana Cavadino(University College London), Joan K. Morris(St George's, University of London), Maria Loane(University of Ulster), Lyubov Yevtushok, Helen Dolk(University of Ulster), Olatz Mokoroa(Biogipuzkoa Health Research Institute), David Tucker(UNSW Sydney), Hanitra Randrianaivo(Centre Hospitalier Universitaire de La Réunion), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Renée Lutke(University Medical Center Groningen), Anna Latos‐Bieleńska(Poznan University of Medical Sciences), Ester Garne(University of Southern Denmark), Lovisa Sandberg(Uppsala Monitoring Centre), Kari Klungsøyr(Norwegian Institute of Public Health), Vera Nelen(Provincial Institute for Hygiene), Anna Pierini(Istituto di Fisiologia Clinica), Tomas Bergvall(Uppsala Monitoring Centre), Inger Öhman(Uppsala Monitoring Centre), Kristina Star(Uppsala Monitoring Centre), Babak Khoshnood(Inserm), Marie-Claude Addor(Centre Hospitalier Universitaire Vaudois), Mary O’Mahony(Health Service Executive), Amanda Nevill(University of Ferrara), Anna Materna‐Kiryluk(Poznan University of Medical Sciences), Ingeborg Barišić(University of Zagreb), Miriam Gatt(Ministry for Health), Anke Rißmann(Otto-von-Guericke-Universität Magdeburg), Nathalie Lelong(Inserm), Awi Wiesel(Johannes Gutenberg University Mainz)
Drug Safety
May 9, 2021
Cited by 17


Related Papers